Kato, Japan

Kazuhito Furukawa

This inventor holds 6 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Nippon Zoki Pharmaceutical Co., Ltd.. Active years: 1998-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuhito Furukawa. Retrieved from https://idiyas.com/inventor/kazuhito-furukawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 50.0

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Katoh-gun, JP (1998 - 2001)
  • Hyogo, JP (2005 - 2011)
  • Kato, JP (2012 - 2014)

Company Filing History:


Years Active: 1998-2014

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Biography of Kazuhito Furukawa

Introduction: Kazuhito Furukawa is a prominent inventor based in Kato, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with histamine receptor antagonistic action. With a total of six patents to his name, Furukawa's work has the potential to alleviate side effects associated with central nervous system medications.

Latest Patents: Among his latest patents is an aminopropylidene derivative, which exhibits excellent histamine receptor antagonistic action. This compound is particularly useful as a pharmaceutical composition, serving as an active ingredient that minimizes side effects in the central nervous system. Additionally, Furukawa has developed an oxepin derivative, which also demonstrates potent histamine receptor antagonistic properties. This compound is noted for its low intracerebral migration, making it a promising candidate for antihistamine applications with reduced side effects such as drowsiness.

Career Highlights: Kazuhito Furukawa is currently employed at Nippon Zoki Pharmaceutical Co., Ltd., where he continues to innovate in the pharmaceutical sector. His research focuses on creating compounds that improve patient outcomes while minimizing adverse effects.

Collaborations: Throughout his career, Furukawa has collaborated with notable colleagues, including Takashi Ogino and Kunihiko Higashiura. These partnerships have contributed to the advancement of his research and

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…